PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400977
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400977
Asia Pacific Biopreservation Market size was valued at USD 610 Million in 2022, expanding at a CAGR of 14.5% from 2023 to 2030.
Using technique of biopreservation, biological products such as stem cells, DNA, tissues, and organs which can have their natural lifespan extended outside of their original environments while still retaining their integrity and functionality. Technological developments that help lower the time, cost, and complexity of the entire process include microarrays or the incorporation of a variety of prediction models, including hybrid models, and different API algorithms.
Biopreservation Market- Market Dynamics
Increasing improved healthcare expenditure and rise in R&D activities are expected to propel market demand
The increasing R&D efforts of biotech and pharmaceutical firms in order to create and produce a vaccine that needed to be bio preserved. For instance, the pandemic led to the USFDA approving the EUA for three mRNA vaccines that Pfizer-BioNTech made in December 2020, Moderna in December 2020, and Janssen in February 2021, according to a paper published in the Stem Cells Translational Medicine Journal. The demand for using biopreservation to create biological products in research and development has increased across several industries, including immunotherapies, the manufacturing of vaccines and antibodies, enzyme technologies, and chemical compounds created biologically. In addition, growing expenditure on boosting healthcare infrastructure is also projected to propel the market growth.
Biopreservation Market- Key Insights
As per the analysis shared by our research analyst, the Asia Pacific market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2023-2030)
Based on Product Type segmentation, equipment segment was predicted to show maximum market share in the year 2022, advancements in technology, equipment in biopreservation have gained high demand in the market.
Based on Application segmentation, biobanking was the leading market in 2022, due to increasing acceptance of sperm and egg banking.
Based on End-User segmentation, medical was the leading market in 2022, due to increasing demand from regenerative medicinal needs, along with R&D requirements.
On the basis of country, China was the leading revenue generator in 2022 mainly due to the growing incidence of degenerative disorders.
The Asia Pacific Biopreservation Market is segmented on the basis of Product Type, Application, End-User, and Region.
The market is divided into four categories based on Product Type: Equipment, media, LIMS, and others. The equipment dominates the market. The rising in demand due to bio preservation of stem cells, DNA, tissue culture, etc.
The market is divided into three categories based on Application: regenerative medicine, bio-banking, drug discovery. The biobanking dominates the market and is likely to maintain its dominance during the forecast period. Pharmaceutical & biotech companies have collaborations with reserve biobanks and tissue preservation with hospitals.
The market is divided into four categories based on End-User: hospitals, medical, pharmaceutical & biotech, and others. Pharmaceutical & biotech segment held the largest share in 2022. The growing opportunities for biologics manufacturing and preservation are mainly boosting the market growth.
Biopreservation Market- Country Insights
Country wise, this market is widespread into India, China, South Korea, Japan, Australia, Thailand, Indonesia, Philippines, Malaysia, Taiwan, Vietnam, Hong Kong, New Zealand, Singapore, Myanmar, and the rest of the Asia-Pacific (APAC) region.
Supporting government initiatives and competitive rivalry will bode well to the market's expansion. Further, a rise in the number of R&D developments undertaken by leading industry participants contributes to the market's growth. This will present advantageous prospects for the growth of the global Biopreservation market. In addition, the biopreservation utility, which preserves cells, tissues, and organs ex vivo for storage, shipment, and transportation, is expected to increase due to the government's substantial investment in drug discovery.
In July 2022, in Chennai, India, Cellutions BioStorage, a cryopreservation bank, will open for business. Cellutions BioStorage is a biomaterial storage and full-service logistics company that works with biopharmaceutical businesses who wish to outsource every aspect of supply chain management across a product's lifetime. The 25,000 square foot, recently completed building has top-notch infrastructure.
The scope of this report covers the market by its major segments, which include as follows:
ASIA PACIFIC BIOPRESERVATION MARKET KEY PLAYERS
BioCision LLC
BioLife Solutions
Panasonic Corporation
Cesca Therapeutics Inc.
Core Dynamics Ltd
Custom Biogenic Systems Inc.
Lifeline Scientific Inc.
Merck KGaA
Princeton CryoTech Inc.
Azenta US Inc.
Thermo Fisher Scientific Inc.
MVE Biological Solutions
VWR International
Others
ASIA PACIFIC BIOPRESERVATION MARKET, BY PRODUCT TYPE
Equipment
Media
LIMS
Others
ASIA PACIFIC BIOPRESERVATION MARKET, BY APPLICATION
Regenerative medicine
Bio-banking
Drug discovery
ASIA PACIFIC BIOPRESERVATION MARKET, BY END-USER
Hospitals
Medical
Pharmaceutical & biotech
Others
ASIA PACIFIC BIOPRESERVATION MARKET, BY REGION
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Malaysia
Taiwan
Vietnam
Hong Kong
New Zealand
Singapore
Myanmar
Rest of APAC